Vaccibody CSO, Agnete Fredriksen together with Professor Bjarne Bogen and Inger Sandlie published a review in Frontiers in Tumor Immunity. […]
Vaccibody receives 2 million € grant from the Norwegian Research Council.
Vaccibody was granted support for the development of a novel therapeutic vaccine against precancerous lesion of the cervix from the […]
Read More… from Vaccibody receives 2 million € grant from the Norwegian Research Council.
Vaccibody raises 875 000 € in new share issues
Vaccibody raises 875 000 € in new share issues. The Norwegian Radium Hospital Research Foundation and Sarsia Seed together invested […]
Read More… from Vaccibody raises 875 000 € in new share issues
Vaccibody in the press
A report addressing solutions for strengthening the Norwegian biotechindustry was handed over to the Norwegian government May 20th. Vaccibody was […]
Multiple opportunities to meet Vaccibody
The European Life Science CEO forum, Zürich March 6-7 BIO Europe Spring, Amsterdam March 19-21 Anglo Nordic Biotech Conference. London […]
ADITEC web site launched
Vaccibody is the only Norwegian partner in the large EU-project, ADITEC. More information on the project is now launched at […]